← Back to Search
Recombinant Human Tumor Necrosis Factor-alpha: Effects On Proliferation Of Normal And Transformed Cells In Vitro.
B. Sugarman, B. Aggarwal, P. Hass, I. Figari, M. Palladino, H. Shepard
Published 1985 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Modulation of the growth of human and murine cell lines in vitro by recombinant human tumor necrosis factor-alpha (rTNF-alpha) and recombinant human interferon-gamma (rIFN-gamma) was investigated. rTNF-alpha had cytostatic or cytolytic effects on only some tumor cell lines. When administered together with rIFN-gamma, rTNF-alpha showed enhanced antiproliferative effects on a subset of the cell lines tested. In contrast to its effects on sensitive tumor cells, rTNF-alpha augmented the growth of normal diploid fibroblasts. Variations in the proliferative response induced by rTNF-alpha were apparently not due to differences in either the number of binding sites per cell or their affinity for rTNF-alpha. These observations indicate that the effects of rTNF-alpha on cell growth are not limited to tumor cells, but rather that this protein may have a broad spectrum of activities in vivo.
This paper references
Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells
B. Beutler (1985)
Enhancement of human MLR by very low concentrations of lipopolysaccharide and blocking of this enhancement by polymyxin B.
G. Spear (1984)
Two distinct tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.
C. Fryling (1985)
Type beta transforming growth factor: a bifunctional regulator of cellular growth.
A. Roberts (1985)
Generation and characterization of a lipopolysaccharide-induced and serum-derived cytotoxic factor for tumor cells.
D. Männel (1980)
Phenotypic characteristics of cell lines requiring interleukin 3 for growth.
J. Ihle (1982)
Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity
P. Gray (1984)
Insulin receptor tyrosine kinase is defective in skeletal muscle of insulin-resistant obese mice
Y. Marchand-Brustel (1985)
Human tumor necrosis factor. Production, purification, and characterization.
B. Aggarwal (1985)
Regulation of cell proliferation and differentiation by interferons.
M. Clemens (1985)
An endotoxin-induced serum factor that causes necrosis of tumors.
E. Carswell (1975)
Preliminary characterization of the tumor cell cytotoxin in tumor necrosis serum.
F. Kull (1981)
Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.
M. Shalaby (1985)
Primary structure of human lymphotoxin derived from 1788 lymphoblastoid cell line.
B. Aggarwal (1985)
Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells.
R. Tucker (1983)
Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin
D. Stone-Wolff (1984)
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
D. Pennica (1984)
Identity of tumour necrosis factor and the macrophage-secreted factor cachectin
B. Beutler (1985)
Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization.
B. Aggarwal (1984)
The synergistic anti-proliferative effect of gamma-interferon and human lymphotoxin.
S. H. Lee (1984)
Isolation of tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.
K. K. Iwata (1985)
A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia.
F. Torti (1985)
Characterization of specific high affinity receptors for human tumor necrosis factor on mouse fibroblasts.
P. Hass (1985)
Natural human interferon-gamma. Complete amino acid sequence and determination of sites of glycosylation.
E. Rinderknecht (1984)
This paper is referenced by
Potential limitation of growth-inhibitory action of recombinant human tumor necrosis factor (PAC-4D) due to easy induction of resistance: evidence in vitro.
M. Hanada (1987)
Growth modulatory effects of a liver-derived growth inhibitor, transforming growth factor β1, and recombinant tumor necrosis factor α, in normal and neoplastic cells
M. Chapekar (1989)
Developments in therapy with monoclonal antibodies and related proteins
H. Shepard (2017)
Metallothioneins as modulators of intestinal inflammation and potential therapeutic targets for inflammatory bowel diseases
L. Devisscher (2014)
Letter regarding "Response to antidepressants and cancer: cause for concern?".
L. J. Brandes (1995)
Role of culture supernatant of cytotoxic/cytostatic macrophages in activation of murine resident peritoneal macrophages
S. Hashimoto (2004)
Detrimental effect of bovine leukemia virus (BLV) on the immunological state of cattle.
Z. Trainin (1996)
Synergistic stimulatory effects of tumour necrosis factor α and interferon γ on replication of human immunodeficiency virus type 1 and on apoptosis of HIV‐1‐infected host cells
X. Han (1996)
Production of tumor necrosis factor-alpha by blood and lung mononuclear phagocytes from patients with human immunodeficiency virus-related lung disease.
A. Millar (1991)
Effects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia.
S. Fujimoto (1992)
Correlation of cytotoxic effect of transmembrane and secretory TNF-α to cell cycle
X. Li (2012)
Wnt/β-Catenin Signaling Enhances Cyclooxygenase-2 (COX2) Transcriptional Activity in Gastric Cancer Cells
F. Núñez (2011)
Human macrophages secrete a tumoricidal activity distinct from tumour necrosis factor-alpha and reactive nitrogen intermediates.
S. Harwix (1992)
[Studies on in vitro anti-tumor activity of tumor necrosis factor alpha against human renal carcinoma cell line (KU-2)].
T. Shibayama (1991)
Tumor necrosis factor (TNF)-alpha directly inhibits human erythropoiesis in vitro: role of p55 and p75 TNF receptors.
L. Rusten (1995)
Linking JNK signaling to NF-κB: a key to survival
S. Papa (2004)
The production of collagen and the activity of mast‐cell chymase increase in human skin after irradiation therapy
R. Riekki (2004)
High dose tumor necrosis factor‐α and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation
M. Gutman (1997)
Paracrine interactions between primary human macrophages and human fibroblasts enhance murine mammary gland humanization in vivo
J. Fleming (2011)
Potentiation of the anti‐tumor effect of actinomycin D by tumor necrosis factor α in mice: Correlation between in vitro and in vivo results
W. Lasek (1996)
Endothelial Cell Death Induced by Tumor Necrosis Factor-α Is Inhibited by the Bcl-2 Family Member, A1*
A. Karsan (1996)
Alterations in TNF-α Signal Transduction in Resistant Human Papillary Thyroid Carcinoma Cells
X. Pang (1996)
Aberrant Expression of Serpin Squamous Cell Carcinoma Antigen 2 in Human Tumor Tissues and Cell Lines: Evidence of Protection from Tumor Necrosis Factor-Mediated Apoptosis
A. Takeda (2002)
An alternative medium supplement for the culturing and growth of human peritoneal mesothelial cells
M. Michelini-Norris (2007)
Potential roles for tumour necrosis factorα during embryonic development
M. Wride (2004)
Monocyte activation for enhanced tumour necrosis factor-alpha and interleukin 6 production during chronic renal allograft rejection.
S. Heidenreich (1994)
Retrovirus-mediated gene transfer in cancer therapy.
W. Uckert (1994)
Antileukemic Activity of TNF-α Therapy with Myeloid Progenitor Cells Against Minimal Leukemia
S. Gautam (1998)
Interferon gamma (IFNgamma ) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways.
K. Suk (2001)
Focal adhesion kinase affects the sensitivity of human hepatocellular carcinoma cell line SMMC-7721 to tumor necrosis factor-alpha/cycloheximide-induced apoptosis by regulating protein kinase B levels.
Y. Fang (2001)
Production of tumor necrosis factor with IgE receptor triggering from sensitized lung tissue.
I. Ohno (1990)
Regulation of lung cell proliferation by polypeptide growth factors.
R. J. King (1989)See more